申请人:Biota Scientific Management PTY Ltd.
公开号:US05990156A1
公开(公告)日:1999-11-23
Compounds of formula (I), ##STR1## wherein R.sup.1 represents OR.sup.5, SR.sup.5, NR.sup.5 R.sup.6, N(OR.sup.5)R.sup.6 or N(NR.sup.5 R.sup.6)R.sup.6 ; X represents OH, N.sub.3, NR.sup.3 R.sup.4 or NR.sup.4 CO.sub.2 R.sup.15 ; Y represents H or NHR.sup.2 ; R.sup.2 represents a group SO.sub.2 R.sup.7 or COR.sup.7 ; R.sup.3 represents H, C.sub.1-6 alkyl or C(.dbd.NR.sup.8)NR.sup.9 R.sup.10 ; R.sup.4 represents H or C.sub.1-6 alkyl; R.sup.5 represents H, C.sub.1-20 alkyl, C.sub.3-8 cycloalkyl, C.sub.2-20 alkenyl, C.sub.2-20 alkynyl, CHR.sup.11 COR.sup.12 or C.sub.1-20 alkyl substituted by one or more groups selected from NR.sup.13 R.sup.14, NR.sup.13 COR.sup.14, CO.sub.2 R.sup.13, OR.sup.13, C.sub.3-8 cycloalkyl and optionally substituted aryl; each R.sup.6 independently represents H, C.sub.1-6 alkyl, C.sub.3-8 cycloalkyl, C.sub.2-6 alkenyl, C.sub.2-20 alkynyl, aryl or C.sub.1-4 alkyl substituted by one or more groups selected from NR.sup.13 R.sup.14, COR.sup.13, C.sub.3-8 cycloalkyl, CN, N.sub.3, OR.sup.13 and optionally substituted aryl; or R.sup.5 and R.sup.6 together form a C.sub.2-6 hydrocarbon chain which may optionally contain a group NR.sup.13 which chain is optionally substituted by 1, 2, 3 or 4 groups selected from oxo and C.sub.1-6 alkyl groups which groups may optionally be substituted by hydroxy or optionally substituted aryl; R.sup.7 represents C.sub.1-6 alkyl optionally substituted by one or more halogen atoms, C.sub.3-8 cycloalkyl or optionally substituted aryl; R.sup.8, R.sup.9 and R.sup.10 each independently represent H, C.sub.1-6 alkyl, amino, hydroxy, cyano or nitro; R.sup.11 represents the side chain of a D- or L-amino acid; R.sup.12 represents NR.sup.13 R.sup.14, OR.sup.13 or R.sup.13 ; each R.sup.13 and each R.sup.14 independently represents H, C.sub.1-6 alkyl or optionally substituted arylC.sub.1-4 alkyl; R.sup.15 represents C.sub.1-6 alkyl; and their pharmaceutically acceptable derivatives are neuraminidase inhibitors useful in the treatment of viral infections.
式(I)的化合物,其中R.sup.1代表OR.sup.5,SR.sup.5,NR.sup.5 R.sup.6,N(OR.sup.5)R.sup.6或N(NR.sup.5 R.sup.6)R.sup.6; X代表OH,N.sub.3,NR.sup.3 R.sup.4或NR.sup.4 CO.sub.2 R.sup.15; Y代表H或NHR.sup.2; R.sup.2代表SO.sub.2 R.sup.7或COR.sup.7基团; R.sup.3代表H,C.sub.1-6烷基或C(.dbd.NR.sup.8)NR.sup.9 R.sup.10; R.sup.4代表H或C.sub.1-6烷基; R.sup.5代表H,C.sub.1-20烷基,C.sub.3-8环烷基,C.sub.2-20烯基,C.sub.2-20炔基,CHR.sup.11 COR.sup.12或C.sub.1-20烷基,其上取代着一个或多个选自NR.sup.13 R.sup.14,NR.sup.13 COR.sup.14,CO.sub.2 R.sup.13,OR.sup.13,C.sub.3-8环烷基和可选取代的芳基的基团; 每个R.sup.6独立地代表H,C.sub.1-6烷基,C.sub.3-8环烷基,C.sub.2-6烯基,C.sub.2-20炔基,芳基或C.sub.1-4烷基,其上取代着一个或多个选自NR.sup.13 R.sup.14,COR.sup.13,C.sub.3-8环烷基,CN,N.sub.3,OR.sup.13和可选取代的芳基的基团; 或R.sup.5和R.sup.6共同形成一个C.sub.2-6烃链,该链可以选择性地含有一个NR.sup.13基团,该链可以取代1、2、3或4个选自氧代和C.sub.1-6烷基基团的基团,这些基团可以选择性地被羟基或可选取代的芳基取代; R.sup.7代表C.sub.1-6烷基,其上可以选择性地取代一个或多个卤素原子,C.sub.3-8环烷基或可选取代的芳基; R.sup.8,R.sup.9和R.sup.10各自独立地表示H,C.sub.1-6烷基,氨基,羟基,氰基或硝基; R.sup.11表示D-或L-氨基酸的侧链; R.sup.12表示NR.sup.13 R.sup.14,OR.sup.13或R.sup.13; 每个R.sup.13和每个R.sup.14独立地表示H,C.sub.1-6烷基或可选取代的芳基C.sub.1-4烷基; R.sup.15表示C.sub.1-6烷基; 它们的药学上可接受的衍生物是神经氨酸酶抑制剂,用于治疗病毒感染。